← Leaderboards
Jennifer K Trittmann
Research Inst Nationwide Children'S Hosp
$768,260
Attributed
$768,260
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $153.7K · FY2016–20$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$768,260 · 1
By mechanism
K08$768,260 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Bernadette Chen$3,224,093
- Chenglong Li$3,890,740
- Kevin M Flanigan$19,837,604
- Sarah Keim$5,704,931
- Bruce A Bunnell$8,257,071
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAlternative TreatmentAngiogenesisAffectApoptosisArginaseArginineAttenuatedBaseAnimal ModelBiological MarkersBlood VesselsBronchopulmonary DysplasiaCaliberCareerCell Culture TechniquesCell ProliferationChildhoodChronic Lung DiseaseClassificationClinical DataBiochemical PathwayComplexComplication
Grant awards (5)
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertension$153,652
K08 · FY2020 · HL · contact PI
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertension$153,652
K08 · FY2019 · HL · contact PI
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertension$153,652
K08 · FY2018 · HL · contact PI
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertension$153,652
K08 · FY2017 · HL · contact PI
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertension$153,652
K08 · FY2016 · HL · contact PI